Overall rank by patents
#13,143
Across all tracked assignees
USPTO PatentsView assignee record - 23 granted patents across 9 technology areas, active 2018–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H10K (ORGANIC ELECTRIC SOLID-STATE DEVICES).
The verdict
Sirigen holds 23 US patents across 9 technology areas, rank #13,143 of 50,000 tracked assignees.
Sirigen II Limited has been granted 23 US utility patents between 2018 and 2025, placing Sirigen II Limited at rank #13,143 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.5 claims per patent with primary concentration in H10K (ORGANIC ELECTRIC SOLID-STATE DEVICES). As a Foreign Corporation, Sirigen II Limited is one of the more focused assignees in the PatentsView dataset. By volume, Sirigen sits between Shanghai Institute OF Pharmaceutical Industry (23 patents, rank #13,139) and Specified Technologies Inc. (23 patents, rank #13,147) - the closest US assignees by grant volume. The composite Innovation Score of 39.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 15 grants, compared with 8 in the 2015–2019 window, a +88% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Sirigen II Limited's 21.5 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Sirigen II Limited against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SHANGHAI INSTITUTE OF PHARMACEUTICAL INDUSTRY
23 patents
SHENZHEN KANGER TECHNOLOGY CO., LTD
23 patents
SHENZHEN YONGCHUANGCHENG TECHNOLOGY CO., LTD.
23 patents
SHINE Technologies, LLC
23 patents
SIXRING INC.
23 patents
SMARTSENS TECHNOLOGY(HK) CO., LIMITED
23 patents
SMW-Autoblok Spannsysteme GmbH
23 patents
SPECIFIED TECHNOLOGIES INC.
23 patents
SIRIGEN II LIMITED
23 patents
What this shows Sirigen holds 23 patents at rank #13,143, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #13,143 in granted patent volume.
Other assignees with the most granted patents in Sirigen's primary technology class.
Sirigen's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 38% higher than 62% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 3 | 13.0% |
| 2019 | 5 | 21.7% |
| 2020 | 1 | 4.3% |
| 2021 | 2 | 8.7% |
| 2022 | 1 | 4.3% |
| 2023 | 1 | 4.3% |
| 2024 | 4 | 17.4% |
| 2025 | 6 | 26.1% |
Top 9 of 9 technology areas
Overall rank by patents
#13,143
Across all tracked assignees
39.5 out of 100
How to use this portfolio
Sirigen's 23 grants land it in the top 38% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.